4//SEC Filing
LEPORE PATRICK G 4
Accession 0001209191-21-067647
CIK 0001566044other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 5:08 PM ET
Size
5.4 KB
Accession
0001209191-21-067647
Insider Transaction Report
Form 4
LEPORE PATRICK G
Director
Transactions
- Purchase
Common Stock
2021-11-30$1.02/sh+12,500$12,699→ 62,500 total
Footnotes (2)
- [F1]Shares were purchased pursuant to a 10b5-1 plan entered into by the reporting person on April 21, 2021.
- [F2]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.98 to $1.03, inclusive. The reporting person undertakes to provide to VYNE Therapeutics Inc., any security holder of VYNE Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001055404
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 5:08 PM ET
- Size
- 5.4 KB